Third dose corrects waning immunity to SARS-CoV-2 mRNA vaccines in immunocompromised patients with immune-mediated inflammatory diseasesMichelle W Cheung, Roya M Dayam, Jaclyn C Law, Rogier L Goetgebuer, Gary Y C Chao, Naomi Finkelstein, Joanne M Stempak, Daniel Pereira, David Croitoru, Lily Acheampong, Saima Rizwan, Jenny D Lee, Darshini Ganatra, Ryan Law, Melanie Delgado-BrandSee the full list of authors
9 September 2022
Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flaresFrancesco Carubbi, Alessia Alunno, Jessica Santilli, Laura Natali, Bernardina Mancini, Nicoletta Di Gregorio, Rita Del Pinto, Angelo Viscido, Davide Grassi, Claudio Ferri
7 September 2022
Humoral and cellular SARS-CoV-2 vaccine responses in patients with giant cell arteritis and polymyalgia rheumaticaYannick van Sleen, Kornelis S M van der Geest, Rosanne D Reitsema, Idil Esen, Janneke H Terpstra, Elisabeth Raveling-Eelsing, Marieke van der Heiden, Thomas Lieber, Annemarie M Buisman, Debbie van Baarle, Maria Sandovici, Elisabeth Brouwer
7 September 2022
Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccinationFilippo Fagni, Katja Schmidt, Daniela Bohr, Larissa Valor-Méndez, Fabian Hartmann, Koray Tascilar, Karin Manger, Bernhard Manger, Arnd Kleyer, David Simon, Georg Schett, Thomas Harrer
19 May 2022
Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two dosesSamuel Bitoun, Jérôme Avouac, Julien Henry, Roba Ghossan, Omar Al Tabaa, Rakiba Belkhir, Gaetane Nocturne, Alice Andrée Mariaggi, Flore Rozenberg, Christelle Vauloup-Fellous, Xavier Mariette, Raphaèle Seror
19 May 2022
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE)Ai Phuong Tran, Daniel Tassone, Johannes Nossent, Nik Sheng Ding
16 May 2022
COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI – the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseasesRim Bourguiba, Maeva Kyheng, Isabelle Koné-Paut, Diane Rouzaud, Jerome Avouac, Mathilde Devaux, Nassim Ait Abdallah, Bruno Fautrel, Nicole Ferreira-Maldent, Vincent Langlois, Emmanuel Ledoult, Hubert Nielly, Viviane Queyrel, Jérémie Sellam, Nathalie TieulieSee the full list of authors
10 May 2022
Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)?Andrew J Laster, Gordon K Lam, Heather S Gladue, Ahmad A Kashif, Erin P Siceloff, Virginia D Lackey, Cheryl R Robertson, Ashley L Toci, Leonard H Calabrese
9 May 2022
Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren’s syndromeGwenny M Verstappen, Liseth de Wolff, Suzanne Arends, Hella-Marie Heiermann, Yannick van Sleen, Annie Visser, Janneke H Terpstra, Dimitri A Diavatopoulos, Marieke van der Heiden, Arjan Vissink, Debbie van Baarle, Frans G M Kroese, Hendrika Bootsma
12 April 2022
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registryJean Liew, Milena Gianfrancesco, Carly Harrison, Zara Izadi, Stephanie Rush, Saskia Lawson-Tovey, Lindsay Jacobsohn, Clairissa Ja, Kimme L Hyrich, Laure Gossec, Anja Strangfeld, Loreto Carmona, Martin Schäfer, Elsa Frãzao-Mateus, Inita BulinaSee the full list of authors
6 April 2022
